An interdisciplinary team led by Cornell has received a five-year grant to launch a new center for engineering, testing and commercializing point-of-care diagnostic devices that will have international reach.
Craniosynostosis, the premature fusion of the top of the skull in infants, is caused by an abnormal excess of a previously unknown type of bone-forming stem cell, according to a preclinical study led by researchers at Weill Cornell Medicine.
Weill Cornell Medicine has been awarded a five-year, $5 million grant from the U.S. Department of Health and Human Services to study whether a bilingual video game can increase the use of contraception among Black and Hispanic adolescents.
The bones that form the spine are derived from a distinct type of stem cell that secretes a protein favoring tumor metastases, according to researchers at Weill Cornell Medicine, a discovery that opens up a new line of research on spinal disorders.
Cornell University’s Life Sciences Technology Innovation Fellowship, formerly known as the BioEntrepreneurship Initiative, enters its second year in 2023-24 with a new cohort of 15 business students and 12 researchers.
The $1.7 million grant will help scientists with expertise in artificial intelligence and machine learning to address complex biomedical challenges in nutrition and health.
A member of an important class of ion channel proteins can transiently rearrange itself into a larger structure with dramatically altered properties, according to a study led by researchers at Weill Cornell Medicine.
